These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6380056)

  • 1. Transplant monitoring with monoclonal antibodies to human T cell subsets by 51Cr release in complement-dependent cytotoxicity (CDC-Cr): a preliminary study.
    Kovithavongs T; Dossetor JB
    Transplant Proc; 1984 Aug; 16(4):1093-6. PubMed ID: 6380056
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement-dependent cytotoxicity detected by 51Cr release: a predictor of kidney graft rejection.
    McConnachie PR; Finch WT; Birtch AG
    Transplant Proc; 1984 Dec; 16(6):1448-50. PubMed ID: 6390846
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody-dependent cell-mediated cytotoxicity in prospective kidney transplant recipients.
    Lightbody JJ; Rosenberg JC
    J Immunol; 1974 Mar; 112(3):890-6. PubMed ID: 4590706
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of lymphocyte-dependent antibodies on human kidney transplants.
    Ting A; Terasaki PI
    Transplantation; 1974 Oct; 18(4):371-3. PubMed ID: 4609299
    [No Abstract]   [Full Text] [Related]  

  • 5. Human T cell subset ratio quantitation by 51Cr release: assessment of a new technique.
    Kovithavongs T; Gramlich L; Dossetor JB
    Clin Invest Med; 1987 Mar; 10(2):78-85. PubMed ID: 3495381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody- and complement-mediated cytolysis against duck-enteritis-virus-infected cells.
    Lam KM
    Avian Dis; 1984; 28(4):1125-9. PubMed ID: 6525133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of indium-111 for studies of cytotoxicity mediated by lymphocytes or by antibodies and complement.
    Ferluga J; Allison AC; Thakur ML
    J Clin Lab Immunol; 1979 Feb; 1(4):339-42. PubMed ID: 501729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic monitoring with monoclonal antibodies to human T-cell subsets.
    Cosimi AB; Colvin RB; Burton RC; Winn HJ; Rubin R; Goldstein G; Kung PC; Hoffman RA; Hansen WP; Russell PS
    Transplant Proc; 1981 Sep; 13(3):1589-93. PubMed ID: 7029820
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological monitoring of renal allograft recipients using monoclonal antibodies to human T lymphocyte subpopulations.
    Ellis TM; Berry CR; Mendez-Picon G; Goldman MH; Lower RR; Lee HM; Mohanakumar T
    Transplantation; 1982 Mar; 33(3):317-9. PubMed ID: 6461117
    [No Abstract]   [Full Text] [Related]  

  • 10. Mapping of binding epitopes of a human decay-accelerating factor monoclonal antibody capable of enhancing rituximab-mediated complement-dependent cytotoxicity.
    Guo B; Ma ZW; Li H; Xu GL; Zheng P; Zhu B; Wu YZ; Zou Q
    Clin Immunol; 2008 Aug; 128(2):155-63. PubMed ID: 18502181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal anti-human T-lymphocyte antibodies: enumeration and characterization of T-cell subsets.
    Van Wauwe J; Goossens J
    Immunology; 1981 Jan; 42(1):157-64. PubMed ID: 6970173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromium-51-release assay of antibody and complement-mediated cytotoxicity for contagious ecthyma virus-infected cells.
    DeMartini JC; Pearson LD; Fiscus SA
    Am J Vet Res; 1978 Dec; 39(12):1922-6. PubMed ID: 107837
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic and prognostic value of donor-specific posttransplant immune responses: clinical correlates and in vitro variables.
    Stiller CR; Sinclair NR; McGirr D; Jevnikar A; Ulan RA
    Transplant Proc; 1978 Sep; 10(3):525-30. PubMed ID: 362629
    [No Abstract]   [Full Text] [Related]  

  • 14. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.
    Kinouchi T; Bander NH; Kotake T
    J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients.
    Akalin E; Ames S; Sehgal V; Fotino M; Daly L; Murphy B; Bromberg JS
    Transplantation; 2003 Nov; 76(10):1444-7. PubMed ID: 14657683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte monitoring in renal transplantation.
    Burton RC
    Transplant Proc; 1984 Aug; 16(4):983-7. PubMed ID: 6380063
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional relationships of lymphocyte membrane structures probed with cytolysis and/or proliferation-inhibiting H35-27.9 and H35-89.9 monoclonal antibodies.
    Golstein P; Pierres M; Schmitt-Verhulst AM; Luciani MF; Buferne M; Eshhar Z; Kaufmann Y
    Adv Exp Med Biol; 1982; 146():487-503. PubMed ID: 6980572
    [No Abstract]   [Full Text] [Related]  

  • 18. Natural cell-mediated cytotoxicity and suppressor activity for natural cell-mediated cytotoxicity in long-term renal transplant patients.
    Ono Y; Kerman RH; Kahan BD
    Transplantation; 1982 Aug; 34(2):103-7. PubMed ID: 6215745
    [No Abstract]   [Full Text] [Related]  

  • 19. Functionally different T lymphocyte subpopulations determined by their sensitivity to complement-dependent cell lysis with the monoclonal antibody 4A.
    Morishima Y; Kobayashi M; Yang SY; Collins NH; Hoffmann MK; Dupont B
    J Immunol; 1982 Sep; 129(3):1091-8. PubMed ID: 6980917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell flow-cytometry crossmatch and long-term renal graft survival.
    Rebibou JM; Bittencourt MC; Saint-Hillier Y; Chabod J; Dupont I; Bittard H; Chalopin JM; Hervé P; Tiberghien P
    Clin Transplant; 2004 Oct; 18(5):558-63. PubMed ID: 15344960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.